Published in Cancer Weekly, September 25th, 1995
Oklahoma Medical Research Foundation (OMRF) scientists Drs. Joan and Ronald Conaway have found a key element in understanding the von Hippel-Lindau tumor suppressor gene that predisposes people to cancer.
"We hope it will lead to the development of new drugs to treat cancer," Conaway said.
The September 18, 1995, issue of Science magazine includes two articles detailing the Conaway's contribution to the project along with collaborators from the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.